112 related articles for article (PubMed ID: 12392546)
1. BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro.
Schmitt-Bernard CF; Chavanieu A; Herrada G; Subra G; Arnaud B; Demaille JG; Calas B; Argilés A
Eur J Biochem; 2002 Nov; 269(21):5149-56. PubMed ID: 12392546
[TBL] [Abstract][Full Text] [Related]
2. In vitro creation of amyloid fibrils from native and Arg124Cys mutated betaIGH3((110-131)) peptides, and its relevance for lattice corneal amyloid dystrophy type I.
Schmitt-Bernard CF; Chavanieu A; Derancourt J; Arnaud B; Demaille JG; Calas B; Argiles A
Biochem Biophys Res Commun; 2000 Jul; 273(2):649-53. PubMed ID: 10873659
[TBL] [Abstract][Full Text] [Related]
3. Effect of position-specific single-point mutations and biophysical characterization of amyloidogenic peptide fragments identified from lattice corneal dystrophy patients.
Anandalakshmi V; Murugan E; Leng EGT; Ting LW; Chaurasia SS; Yamazaki T; Nagashima T; George BL; Peh GSL; Pervushin K; Lakshminarayanan R; Mehta JS
Biochem J; 2017 May; 474(10):1705-1725. PubMed ID: 28381645
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
5. Identification of an amyloidogenic region on keratoepithelin via synthetic peptides.
Yuan C; Berscheit HL; Huang AJ
FEBS Lett; 2007 Jan; 581(2):241-7. PubMed ID: 17207483
[TBL] [Abstract][Full Text] [Related]
6. Two mutations in the TGFBI (BIGH3) gene associated with lattice corneal dystrophy in an extensively studied family.
Klintworth GK; Bao W; Afshari NA
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1382-8. PubMed ID: 15111592
[TBL] [Abstract][Full Text] [Related]
7. TGFBI (BIGH3) gene mutations in Hungary--report of the novel F547S mutation associated with polymorphic corneal amyloidosis.
Takács L; Losonczy G; Matesz K; Balogh I; Sohajda Z; Tóth K; Fazakas F; Vereb G; Berta A
Mol Vis; 2007 Oct; 13():1976-83. PubMed ID: 17982422
[TBL] [Abstract][Full Text] [Related]
8. A mutation within exon 14 of the TGFBI (BIGH3) gene on chromosome 5q31 causes an asymmetric, late-onset form of lattice corneal dystrophy.
Stewart H; Black GC; Donnai D; Bonshek RE; McCarthy J; Morgan S; Dixon MJ; Ridgway AA
Ophthalmology; 1999 May; 106(5):964-70. PubMed ID: 10328397
[TBL] [Abstract][Full Text] [Related]
9. Corneal dystrophies in Japan.
Fujiki K; Nakayasu K; Kanai A
J Hum Genet; 2001; 46(8):431-5. PubMed ID: 11501939
[TBL] [Abstract][Full Text] [Related]
10. Hereditary lattice corneal dystrophy is associated with corneal amyloid deposits enclosing C-terminal fragments of keratoepithelin.
Stix B; Leber M; Bingemer P; Gross C; Rüschoff J; Fändrich M; Schorderet DF; Vorwerk CK; Zacharias M; Roessner A; Röcken C
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1133-9. PubMed ID: 15790870
[TBL] [Abstract][Full Text] [Related]
11. [BIG-H3 protein: mutation of codon 124 and corneal amyloidosis].
Schmitt-Bernard CF; Pouliquen Y; Argilès A
J Fr Ophtalmol; 2004 May; 27(5):510-22. PubMed ID: 15179309
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides.
Rijkers DT; Höppener JW; Posthuma G; Lips CJ; Liskamp RM
Chemistry; 2002 Sep; 8(18):4285-91. PubMed ID: 12298020
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in human corneal and HeLa cells by mutated BIGH3.
Morand S; Buchillier V; Maurer F; Bonny C; Arsenijevic Y; Munier FL; Schorderet DF
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2973-9. PubMed ID: 12824240
[TBL] [Abstract][Full Text] [Related]
14. BIGH3 exon 14 mutations lead to intermediate type I/IIIA of lattice corneal dystrophies.
Schmitt-Bernard CF; Guittard C; Arnaud B; Demaille J; Argiles A; Claustres M; Tuffery-Giraud S
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1302-8. PubMed ID: 10798644
[TBL] [Abstract][Full Text] [Related]
15. [Case of late onset and isolated lattice corneal dystrophy with Asn544Ser (N544S) mutation of transforming growth factor beta-induced (TGFBI, BIGH3) gene].
Nakagawa Asahina S; Fujiki K; Enomoto Y; Murakami A; Kanai A
Nippon Ganka Gakkai Zasshi; 2004 Oct; 108(10):618-20. PubMed ID: 15559315
[TBL] [Abstract][Full Text] [Related]
16. A corneal dystrophy associated with transforming growth factor beta-induced Gly623Asp mutation an amyloidogenic phenotype.
Auw-Haedrich C; Agostini H; Clausen I; Reinhard T; Eberwein P; Schorderet DF; Gruenauer-Kloevekorn C
Ophthalmology; 2009 Jan; 116(1):46-51. PubMed ID: 19019446
[TBL] [Abstract][Full Text] [Related]
17. Late-onset lattice corneal dystrophy without typical lattice lines caused by a novel mutation in the TGFBI gene.
Ołdak M; Szaflik JP; Ścieżyńska A; Udziela M; Maksym RB; Rymgayłło-Jankowska B; Hofmann-Rummelt C; Menzel-Severing J; Płoski R; Żarnowski T; Kruse FE; Szaflik J
Cornea; 2014 Mar; 33(3):294-9. PubMed ID: 24473223
[TBL] [Abstract][Full Text] [Related]
18. Spheroidal degeneration in H626R TGFBI variant lattice dystrophy: a multimodality analysis.
Lai K; Reidy J; Bert B; Milman T
Cornea; 2014 Jul; 33(7):726-32. PubMed ID: 24831201
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic aspects of the TGFBI-associated corneal dystrophies.
Lakshminarayanan R; Chaurasia SS; Anandalakshmi V; Chai SM; Murugan E; Vithana EN; Beuerman RW; Mehta JS
Ocul Surf; 2014 Oct; 12(4):234-51. PubMed ID: 25284770
[TBL] [Abstract][Full Text] [Related]
20. In vitro amyloid aggregate forming ability of TGFBI mutants that cause corneal dystrophies.
Yam GH; Wang K; Jhanji V; Choy KW; Baum L; Pang CP
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5890-8. PubMed ID: 22850414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
